Last $7.42 USD
Change Today -0.37 / -4.75%
Volume 25.4K
IRIX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GM
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

iridex corp (IRIX) Key Developments

IRIDEX Corporation Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-12-2014 01:55 PM

IRIDEX Corporation Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-12-2014 01:55 PM. Venue: Le Parker Meridien, New York, New York, United States. Speakers: William M. Moore, Chairman of the Board, Interim Chief Executive Officer and Interim President.

Garrett A. Garrettson Resigns from the Board of Directors of Iridex Corporation

On July 29, 2014, Dr. Garrett A. Garrettson resigned from the Board of Directors of IRIDEX Corporation and all committees thereof, effective July 29, 2014.

IRIDEX Corporation Announces Consolidated Unaudited Earnings Results for Second Quarter and Six Months Ended June 28, 2014; Provides Earnings Guidance for Third Quarter of 2014

IRIDEX Corporation announced consolidated unaudited earnings results for second quarter and six months ended June 28, 2014. For the quarter, the company reported total revenues of $10,589,000, income from operations of $400,000, income from operations before provision for income taxes of $309,000, net income of $297,000 or $0.03 basic and diluted per share compared to the total revenues of $9,210,000, income from operations of $515,000, income from operations before provision for income taxes of $418,000, net income of $415,000 or $0.04 diluted per share for the same quarter a year ago. For the six months, the company reported total revenues of $20,918,000, income from operations of $997,000, income from operations before provision for income taxes of $809,000, net income of $784,000 or $0.07 diluted per share compared to the total revenues of $18,149,000, income from operations of $1,412,000, income from operations before provision for income taxes of $1,297,000, net income of $1,289,000 or $0.13 diluted per share for the same quarter a year ago. The company provided earnings guidance for third quarter of 2014. The company expects to achieve revenue of $10.0 million to $10.3 million, representing growth of 5% to 8% over last year's third quarter. Gross margin is anticipated to come in between 48% and 50%, and operating expenses are expected to be $4.6 million to $4.8 million.

IRIDEX Corporation to Report Q2, 2014 Results on Jul 31, 2014

IRIDEX Corporation announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Jul 31, 2014

IRIDEX Corporation, Q2 2014 Earnings Call, Jul 31, 2014

IRIDEX Corporation, Q2 2014 Earnings Call, Jul 31, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRIX:US $7.42 USD -0.37

IRIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cutera Inc $10.44 USD +0.24
Ellex Medical Lasers Ltd A$0.32 AUD -0.01
Lutronic Corp 19,950 KRW -300.00
Quantel SA €3.69 EUR +0.13
Synergetics USA Inc $3.31 USD 0.00
View Industry Companies
 

Industry Analysis

IRIX

Industry Average

Valuation IRIX Industry Range
Price/Earnings 44.7x
Price/Sales 1.8x
Price/Book 2.9x
Price/Cash Flow 42.5x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRIDEX CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.